Cart
0

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Get 20% Free Customization In This Report
LI_16391
Pages: 235
May 2018 | 9964 Views
 
Author's : Tenzin Kunsel and Garima Chandra
Tables: 96
Charts: 54
 

Regenerative Medicine Market Overview:

Regenerative medicines are used to repair, replace, and regenerate tissues and organs affected by injury, disease, or natural aging process. These medicines restore the functionality of cells & tissues and are used in several degenerative disorders such as dermatology, neurodegenerative diseases, cardiovascular, and orthopedic applications. Stem cells are capable of proliferation and differentiation, which increase their importance in this field. The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023.

The factors driving the growth of this market include emergence of stem cell technology, untapped potential of nanotechnology, increase in prevalence of chronic diseases & trauma emergencies, advancement in monitoring devices and surgical technologies, rise in incidence of degenerative diseases, and shortage of organs for transplantation. Increase in focus on stem cells and growth in R&D activities in emerging economies are expected to supplement the market growth. The developing nations are focused on technological advancements, which is expected to boost the market growth, globally. However, stringent government regulations, operational inefficiency, and high cost of treatment through regenerative medicine are estimated to hamper the growth of the market.

Product Type Segment Review

Based on product type, the market is segmented into cell therapy, gene therapy, tissue engineering, and small molecules & biologics. Moreover, among all the regenerative medicine products, the cell therapy segment has the most promising future due to its efficiency to restore the lost function of tissues and organs. In addition, the small molecules & biologics segment is expected to grow at the highest CAGR of 33.3% from 2017 to 2023, due to its potential to stimulate dormant or endogenous cells to regain their regenerative properties.

Get more information on this report : Request Sample Pages

Material Segment Review

Based on material, the market is divided into synthetic material, biologically derived material, genetically engineered material, and pharmaceutical. The biologically derived material was the dominant segment in 2016, and is estimated to maintain this trend during the analysis period. The demand for genetically engineered material has increased due to their unique properties such as promotion of cellular interactions, increased proliferation, and differentiation of cells that facilitate self-assembly into directionally organized structures, and control the manipulation of cellular behavior.

Get more information on this report : Request Sample Pages

Key Geographical Segment

As per region, the regenerative medicine market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in 2016, and is expected to retain its dominance throughout the forecast period.

Get more information on this report : Request Sample Pages

The key players operating in the global regenerative medicine market include Stryker Corporation, Zimmer Biomet Holdings, Inc., Medtronic Plc., Athersys, Inc., U.S. Stem Cell, Inc. (Bioheart, Inc.), Organogenesis, Inc. (Advanced Biohealing), Integra Lifesciences Holdings Corporation, Acelity Holdings, Inc., Isto Biologics (Isto Biologics Medical Systems, Inc.), and CryoLife, Inc.

Other prominent players in the value chain include Shimadzu Recursion Pharmaceuticals, Inc., Baxter International, Inc., DePuy Synthes Siemens Healthineers, General Electric (GE) Company, Koninklijke Philips N.V., Cloudmedx, Inc., and Bay Labs, Inc.

Key Benefits for Stakeholders

  • This report entails a detailed quantitative analysis of the market trends from 2016 to 2023 to identify the prevailing opportunities.
  • Market estimations are based on a comprehensive analysis of the key developments in the industry.
  • The global market is comprehensively analyzed with respect to product type, material, application, and region.
  • An in-depth analysis based on geography helps to understand the regional market to assist in strategic business planning.
  • The development strategies adopted by the key manufacturers are enlisted to understand the competitive scenario of the market.

Regenerative Medicine Market Key Segments:

By Product Type

  • Cell Therapy
  • Gene Therapy
  • Tissue Engineering
  • Small Molecule & Biologic

By Material

  • Synthetic Material
    • Biodegradable Synthetic Polymer
    • Scaffold
    • Artificial Vascular Graft Material
    • Hydrogel Material
  • Biologically Derived Material
    • Collagen
    • Xenogeneic Material
  • Genetically Engineered Material
    • Deoxyribonucleic Acid Transfection Vector
    • Genetically Manipulated Cell
    • Three-Dimensional Polymer Technology
    • Transgenic
    • Fibroblast
    • Neural Stem Cell
    • Gene-Activated Matrices
  • Pharmaceuticals
    • Small Molecule
    • Biologic

By Application

  • Cardiovascular
  • Oncology
  • Dermatology
  • Musculoskeletal
  • Wound Healing
  • Ophthalmology
  • Neurology
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Russia
    • Netherlands
    • Sweden
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • Singapore
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Turkey
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

Chapter: 1: INTRODUCTION

1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.4. Research Methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

Chapter: 3: MARKET OVERVIEW

3.1. Market Definition And Scope
3.2. Key Findings

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. Porter’s Five Forces Analysis
3.4. Market Dynamics

3.4.1. Drivers

3.4.1.1. High adoption of stem cell technology
3.4.1.2. Emerging application of nanotechnology
3.4.1.3. Increasing prevalence of chronic diseases and trauma emergencies
3.4.1.4. Advancements in medical equipment technologies

3.4.2. Restraints

3.4.2.1. Ethical hurdles
3.4.2.2. Costly treatment associated with regenerative medicine

3.4.3. Opportunities

3.4.3.1. Lucrative opportunities of novel stem cell technologies
3.4.3.2. Increasing potential in emerging economies
3.4.3.3. Growing need of regenerative medicine in organ transplantation

Chapter: 4: REGENERATIVE MEDICINE MARKET, BY PRODUCT TYPE

4.1. Overview

4.1.1. Market size and forecast

4.2. Cell Therapy

4.2.1. Key market trends
4.2.2. Key growth factors and growth opportunities
4.2.3. Market size and forecast

4.3. Gene Therapy

4.3.1. Key market trends
4.3.2. Key growth factors and growth opportunities
4.3.3. Market size and forecast

4.4. Tissue Engineering

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast

4.5. Small Molecules And Biologics

4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast

Chapter: 5: REGENERATIVE MEDICINE MARKET, BY MATERIAL

5.1. Overview

5.1.1. Market size and forecast

5.2. Synthetic Materials

5.2.1. Market size and forecast, by region
5.2.2. Market size and forecast, by type
5.2.3. Biodegradable synthetic polymers

5.2.3.1. Market size and forecast

5.2.4. Scaffold

5.2.4.1. Market size and forecast

5.2.5. Artificial vascular graft materials

5.2.5.1. Market size and forecast

5.2.6. Hydrogel material

5.2.6.1. Market size and forecast

5.3. Biologically Derived Materials

5.3.1. Market size and forecast, by region
5.3.2. Market size and forecast, by type
5.3.3. Collagen

5.3.3.1. Market size and forecast

5.3.4. Xenogeneic material

5.3.4.1. Market size and forecast

5.4. Genetically Engineered Materials

5.4.1. Market size and forecast, by region
5.4.2. Market size and forecast, by type
5.4.3. Deoxyribonucleic acid transfection vectors

5.4.3.1. Market size and forecast

5.4.4. Genetically manipulated cells

5.4.4.1. Market size and forecast

5.4.5. Three-dimensional polymer technology

5.4.5.1. Market size and forecast

5.4.6. Transgenics

5.4.6.1. Market size and forecast

5.4.7. Fibroblasts

5.4.7.1. Market size and forecast

5.4.8. Neural stem cells

5.4.8.1. Market size and forecast

5.4.9. Gene-activated matrices

5.4.9.1. Market size and forecast

5.5. Pharmaceuticals

5.5.1. Market size and forecast, by region
5.5.2. Market size and forecast, by type
5.5.3. Small molecules

5.5.3.1. Market size and forecast

5.5.4. Biologics

5.5.4.1. Market size and forecast

Chapter: 6: REGENERATIVE MEDICINE MARKET, BY APPLICATION

6.1. Overview

6.1.1. Market size and forecast

6.2. Cardiovascular

6.2.1. Market size and forecast

6.3. Oncology

6.3.1. Market size and forecast

6.4. Dermatology

6.4.1. Market size and forecast

6.5. Musculoskeletal

6.5.1. Market size and forecast

6.6. Wound Healing

6.6.1. Market size and forecast

6.7. Ophthalmology

6.7.1. Market size and forecast

6.8. Neurology

6.8.1. Market size and forecast

6.9. Others

6.9.1. Market size and forecast

Chapter: 7: REGENERATIVE MEDICINE MARKET, BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North America

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast, by product type
7.2.4. Market size and forecast, by material
7.2.5. Market size and forecast, by application
7.2.6. Market size and forecast, by country

7.2.6.1. U.S. market size and forecast
7.2.6.2. Canada market size and forecast
7.2.6.3. Mexico market size and forecast

7.3. Europe

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast, by product type
7.3.4. Market size and forecast, by material
7.3.5. Market size and forecast, by application
7.3.6. Market size and forecast, by country

7.3.6.1. Germany market size and forecast
7.3.6.2. France market size and forecast
7.3.6.3. UK market size and forecast
7.3.6.4. Italy market size and forecast
7.3.6.5. Spain market size and forecast
7.3.6.6. Russia market size and forecast
7.3.6.7. Rest of Europe market size and forecast

7.4. Asia-Pacific

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast, by product type
7.4.4. Market size and forecast, by material
7.4.5. Market size and forecast, by application
7.4.6. Market size and forecast, by country

7.4.6.1. Japan market size and forecast
7.4.6.2. China market size and forecast
7.4.6.3. Australia market size and forecast
7.4.6.4. India market size and forecast
7.4.6.5. South Korea market size and forecast
7.4.6.6. Taiwan market size and forecast
7.4.6.7. Rest of Asia-Pacific market size and forecast

7.5. Lamea

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast, by product type
7.5.4. Market size and forecast, by material
7.5.5. Market size and forecast, by application
7.5.6. Market size and forecast, by country

7.5.6.1. Brazil market size and forecast
7.5.6.2. Turkey market size and forecast
7.5.6.3. Venezuela market size and forecast
7.5.6.4. Saudi Arabia market size and forecast
7.5.6.5. South Africa market size and forecast
7.5.6.6. Rest of LAMEA market size and forecast

Chapter: 8: COMPANY PROFILES

8.1. Acelity Holdings, Inc. (Lifecell Corporation)

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Key strategic moves and developments

8.2. Athersys, Inc.

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Business performance
8.2.5. Key strategic moves and developments

8.3. Cryolife, Inc.

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Business performance

8.4. Integra Lifesciences Corporation

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Business performance
8.4.5. Key strategic moves and developments

8.5. Isto Biologics (Isto Biologics Medical Systems, Inc.)

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Key strategic moves and developments

8.6. Medtronic Plc

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Business performance

8.7. Organogenesis Inc.

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Key strategic moves and developments

8.8. Stryker Corporation

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Business performance
8.8.5. Key strategic moves and developments

8.9. U.S. Stem Cell, Inc. (Bioheart, Inc.)

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Business performance
8.9.5. Key strategic moves and developments

8.10. Zimmer Biomet Holdings, Inc.

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Business performance
8.10.5. Key strategic moves and developments

LIST OF TABLES

TABLE 01. UNINTENTIONAL INJURIES FACTS (2013)
TABLE 02. GLOBAL REGENERATIVE MEDICINE MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 03. REGENERATIVE MEDICINE MARKET FOR CELL THERAPY, BY REGION, 2016-2023 ($MILLION)
TABLE 04. REGENERATIVE MEDICINE MARKET FOR GENE THERAPY, BY REGION, 2016-2023 ($MILLION)
TABLE 05. REGENERATIVE MEDICINE MARKET FOR TISSUE ENGINEERING, BY REGION, 2016-2023 ($MILLION)
TABLE 06. REGENERATIVE MEDICINE MARKET FOR SMALL MOLECULES & BIOLOGICS, BY REGION, 2016-2023 ($MILLION)
TABLE 07. GLOBAL REGENERATIVE MEDICINE MARKET, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 08. REGENERATIVE MEDICINE MARKET FOR SYNTHETIC MATERIAL, BY REGION, 2016-2023 ($MILLION)
TABLE 09. REGENERATIVE MEDICINE MARKET FOR SYNTHETIC MATERIAL, BY TYPE, 2016-2023 ($MILLION)
TABLE 10. CLASSIFICATION OF BIODEGRADABLE POLYMERS
TABLE 11. REGENERATIVE MEDICINE MARKET FOR BIODEGRADABLE SYNTHETIC POLYMER, BY REGION, 2016-2023 ($MILLION)
TABLE 12. CLASSIFICATION OF BIODEGRADABLE POLYMERS
TABLE 13. REGENERATIVE MEDICINE MARKET FOR SCAFFOLD, BY REGION, 2016-2023 ($MILLION)
TABLE 14. REGENERATIVE MEDICINE MARKET FOR ARTIFICIAL VASCULAR GRAFT MATERIALS, BY REGION, 2016-2023 ($MILLION)
TABLE 15. REGENERATIVE MEDICINE MARKET FOR HYDROGEL MATERIAL, BY REGION, 2016-2023 ($MILLION)
TABLE 16. REGENERATIVE MEDICINE MARKET FOR BIOLOGICALLY DERIVED MATERIALS, BY REGION, 2016-2023 ($MILLION)
TABLE 17. REGENERATIVE MEDICINE MARKET FOR BIOLOGICALLY DERIVED MATERIALS, BY TYPE, 2016-2023 ($MILLION)
TABLE 18. REGENERATIVE MEDICINE MARKET FOR COLLAGEN MATERIAL, BY REGION, 2016-2023 ($MILLION)
TABLE 19. REGENERATIVE MEDICINE MARKET FOR XENOGENEIC MATERIAL, BY REGION, 2016-2023 ($MILLION)
TABLE 20. REGENERATIVE MEDICINE MARKET FOR GENETICALLY ENGINEERED MATERIALS, BY REGION, 2016-2023 ($MILLION)
TABLE 21. REGENERATIVE MEDICINE MARKET FOR GENETICALLY ENGINEERED MATERIALS, BY TYPE, 2016-2023 ($MILLION)
TABLE 22. REGENERATIVE MEDICINE MARKET FOR DEOXYRIBONUCLEIC ACID TRANSFECTION VECTORS, BY REGION, 2016-2023 ($MILLION)
TABLE 23. REGENERATIVE MEDICINE MARKET FOR GENETICALLY MANIPULATED CELLS, BY REGION, 2016-2023 ($MILLION)
TABLE 24. REGENERATIVE MEDICINE MARKET FOR THREE-DIMENSIONAL POLYMER TECHNOLOGY, BY REGION, 2016-2023 ($MILLION)
TABLE 25. REGENERATIVE MEDICINE MARKET FOR TRANSGENICS, BY REGION, 2016-2023 ($MILLION)
TABLE 26. REGENERATIVE MEDICINE MARKET FOR FIBROBLASTS, BY REGION, 2016-2023 ($MILLION)
TABLE 27. REGENERATIVE MEDICINE MARKET FOR NEURAL STEM CELLS, BY REGION, 2016-2023 ($MILLION)
TABLE 28. REGENERATIVE MEDICINE MARKET FOR GENE-ACTIVATED MATRICES, BY REGION, 2016-2023 ($MILLION)
TABLE 29. REGENERATIVE MEDICINE MARKET FOR PHARMACEUTICALS, BY REGION, 2016-2023 ($MILLION)
TABLE 30. REGENERATIVE MEDICINE MARKET FOR PHARMACEUTICALS, BY TYPE, 2016-2023 ($MILLION)
TABLE 31. REGENERATIVE MEDICINE MARKET FOR SMALL MOLECULES, BY REGION, 2016-2023 ($MILLION)
TABLE 32. REGENERATIVE MEDICINE MARKET FOR BIOLOGICS, BY REGION, 2016-2023 ($MILLION)
TABLE 33. GLOBAL REGENERATIVE MEDICINE MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 34. REGENERATIVE MEDICINE MARKET FOR CARDIOVASCULAR, BY REGION, 2016-2023 ($MILLION)
TABLE 35. REGENERATIVE MEDICINE MARKET FOR ONCOLOGY, BY REGION, 2016-2023 ($MILLION)
TABLE 36. STATISTICS FOR SKIN DAMAGE MEDICAL CONDITIONS IN THE U.S. AND WORLDWIDE, 2011
TABLE 37. LIST OF ACELLULAR SKIN TISSUE-ENGINEERED PRODUCTS IN THE MARKET
TABLE 38. LIST OF CELLULAR SKIN TISSUE-ENGINEERED PRODUCTS IN THE MARKET
TABLE 39. REGENERATIVE MEDICINE MARKET FOR DERMATOLOGY, BY REGION, 2016-2023 ($MILLION)
TABLE 40. STATISTICS FOR BONE DAMAGE AND RELATED DISEASES, 2011
TABLE 41. STATISTICS FOR CARTILAGE DAMAGE WORLDWIDE
TABLE 42. REGENERATIVE MEDICINE MARKET FOR MUSCULOSKELETAL, BY REGION, 2016-2023 ($MILLION)
TABLE 43. REGENERATIVE MEDICINE MARKET FOR WOUND HEALING, BY REGION, 2016-2023 ($MILLION)
TABLE 44. REGENERATIVE MEDICINE MARKET FOR OPHTHALMOLOGY, BY REGION, 2016-2023 ($MILLION)
TABLE 45. REGENERATIVE MEDICINE MARKET FOR NEUROLOGY, BY REGION, 2016-2023 ($MILLION)
TABLE 46. REGENERATIVE MEDICINE MARKET FOR OTHER APPLICATION, BY REGION, 2016-2023 ($MILLION)
TABLE 47. REGENERATIVE MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 48. NORTH AMERICA REGENERATIVE MEDICINE MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 49. NORTH AMERICA REGENERATIVE MEDICINE MARKET, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 50. NORTH AMERICA REGENERATIVE MEDICINE MARKET FOR SYNTHETIC MATERIAL, 2016-2023 ($MILLION)
TABLE 51. NORTH AMERICA REGENERATIVE MEDICINE MARKET FOR BIOLOGICALLY DERIVED MATERIAL, 2016-2023 ($MILLION)
TABLE 52. NORTH AMERICA REGENERATIVE MEDICINE MARKET FOR GENETICALLY ENGINEERED MATERIAL, 2016-2023 ($MILLION)
TABLE 53. NORTH AMERICA REGENERATIVE MEDICINE MARKET FOR PHARMACEUTICALS, 2016-2023 ($MILLION)
TABLE 54. NORTH AMERICA REGENERATIVE MEDICINE MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 55. NORTH AMERICA REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 56. EUROPE REGENERATIVE MEDICINE MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 57. EUROPE REGENERATIVE MEDICINE MARKET, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 58. EUROPE REGENERATIVE MEDICINE MARKET FOR SYNTHETIC MATERIAL, 2016-2023 ($MILLION)
TABLE 59. EUROPE REGENERATIVE MEDICINE MARKET FOR BIOLOGICALLY DERIVED MATERIAL, 2016-2023 ($MILLION)
TABLE 60. EUROPE REGENERATIVE MEDICINE MARKET FOR GENETICALLY ENGINEERED MATERIAL, 2016-2023 ($MILLION)
TABLE 61. EUROPE REGENERATIVE MEDICINE MARKET FOR PHARMACEUTICALS, 2016-2023 ($MILLION)
TABLE 62. EUROPE REGENERATIVE MEDICINE MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 63. EUROPE REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 64. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 65. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 66. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET FOR SYNTHETIC MATERIAL, 2016-2023 ($MILLION)
TABLE 67. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET FOR BIOLOGICALLY DERIVED MATERIAL, 2016-2023 ($MILLION)
TABLE 68. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET FOR GENETICALLY ENGINEERED MATERIAL, 2016-2023 ($MILLION)
TABLE 69. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET FOR PHARMACEUTICALS, 2016-2023 ($MILLION)
TABLE 70. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 71. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 72. LAMEA REGENERATIVE MEDICINE MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 73. LAMEA REGENERATIVE MEDICINE MARKET, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 74. LAMEA REGENERATIVE MEDICINE MARKET FOR SYNTHETIC MATERIAL, 2016-2023 ($MILLION)
TABLE 75. LAMEA REGENERATIVE MEDICINE MARKET FOR BIOLOGICALLY DERIVED MATERIAL, 2016-2023 ($MILLION)
TABLE 76. LAMEA REGENERATIVE MEDICINE MARKET FOR GENETICALLY ENGINEERED MATERIAL, 2016-2023 ($MILLION)
TABLE 77. LAMEA REGENERATIVE MEDICINE MARKET FOR PHARMACEUTICALS, 2016-2023 ($MILLION)
TABLE 78. LAMEA REGENERATIVE MEDICINE MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 79. LAMEA REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 80. ACELITY: COMPANY SNAPSHOT
TABLE 81. ACELITY: THREE TECHNOLOGIES
TABLE 82. ATHERSYS: COMPANY SNAPSHOT
TABLE 83. ATHERSYS: OPERATING SEGMENTS
TABLE 84. CRYOLIFE: COMPANY SNAPSHOT
TABLE 85. CRYOLIFE: PRODUCT CATEGORIES
TABLE 86. INTEGRA LIFESCIENCES: COMPANY SNAPSHOT
TABLE 87. INTEGRA LIFESCIENCES: OPERATING SEGMENTS
TABLE 88. ISTO BIOLOGICS: COMPANY SNAPSHOT
TABLE 89. MEDTRONIC: COMPANY SNAPSHOT
TABLE 90. MEDTRONIC: PRODUCT CATEGORIES
TABLE 91. ORGANOGENESIS: COMPANY SNAPSHOT
TABLE 92. STRYKER: COMPANY SNAPSHOT
TABLE 93. STRYKER: OPERATING SEGMENTS
TABLE 94. US STEM CELL: COMPANY SNAPSHOT
TABLE 95. ZIMMER BIOMET: COMPANY SNAPSHOT
TABLE 96. ZIMMER BIOMET: OPERATING SEGMENTS

LIST OF FIGURES

FIGURE 01. GLOBAL REGENERATIVE MEDICINE MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2016-2018*
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2016-2018* (%)
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2016-2018*
FIGURE 06. LOW BARGAINING POWER OF BUYERS
FIGURE 07. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 08. HIGH THREAT OF NEW ENTRANTS
FIGURE 09. LOW THREAT OF SUBSTITUTION
FIGURE 10. HIGH COMPETITIVE RIVALRY
FIGURE 11. U.S. REGENERATIVE MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 12. CANADA REGENERATIVE MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 13. MEXICO REGENERATIVE MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 14. GERMANY REGENERATIVE MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 15. FRANCE REGENERATIVE MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 16. UK REGENERATIVE MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 17. ITALY REGENERATIVE MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 18. SPAIN REGENERATIVE MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 19. RUSSIA REGENERATIVE MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 20. REST OF EUROPE REGENERATIVE MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 21. JAPAN REGENERATIVE MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 22. CHINA REGENERATIVE MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 23. AUSTRALIA REGENERATIVE MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 24. INDIA REGENERATIVE MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 25. SOUTH KOREA REGENERATIVE MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 26. TAIWAN REGENERATIVE MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 27. REST OF ASIA-PACIFIC REGENERATIVE MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 28. BRAZIL REGENERATIVE MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 29. TURKEY REGENERATIVE MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 30. VENEZUELA REGENERATIVE MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 31. SAUDI ARABIA REGENERATIVE MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 32. SOUTH AFRICA REGENERATIVE MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 33. REST OF LAMEA REGENERATIVE MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 34. ATHERSYS: REVENUE, 2015-2017 ($MILLION)
FIGURE 35. ATHERSYS: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 36. ATHERSYS: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 37. CRYOLIFE: REVENUE, 2015-2017 ($MILLION)
FIGURE 38. CRYOLIFE: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 39. CRYOLIFE: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 40. INTEGRA LIFESCIENCES: REVENUE, 2015-2017 ($MILLION)
FIGURE 41. INTEGRA LIFESCIENCES: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 42. INTEGRA LIFESCIENCES: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 43. MEDTRONIC: NET SALES, 2015-2017 ($MILLION)
FIGURE 44. MEDTRONIC: REVENUE SHARE PER SEGMENT 2017 (%)
FIGURE 45. MEDTRONIC: REVENUE SHARE BY GEOGRAPHY 2017 (%)
FIGURE 46. STRYKER: REVENUE, 2015-2017 ($MILLION)
FIGURE 47. STRYKER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 48. STRYKER LIFESCIENCES: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 49. US STEM CELL: REVENUE, 2015-2017 ($MILLION)
FIGURE 50. US STEM CELL: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 51. US STEM CELL: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 52. ZIMMER BIOMET: REVENUE, 2015-2017 ($MILLION)
FIGURE 53. ZIMMER BIOMET: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 54. ZIMMER BIOMET: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

 

The demand for synthetic and biologically derived materials is high in the market due to their characteristics such as cellular adoption and high immune response. Tissue engineering and regenerative medicine are widely used in the biomedical sector for regeneration and repair of diseased or traumatized tissues. Tissue regeneration is conducted both in vitro and in vivo conditions. Tissue engineering requires artificial matrix for regeneration of tissues. This artificial matrix aids in the proliferation and differentiation of cells, leading to the regeneration of tissues. The demand for synthetic tissue engineering material is currently high due to its higher efficiency as compared to other naturally derived materials.

The recent progress in the design of synthetic materials has led to the use of hydrogel in tissue-engineered scaffolds. These synthetic materials comprise interlinked polymers that form a network-like structure through physical and chemical cross-linking. Although the synthetic materials used in tissue engineering hold promising potential in the market in terms of revenue, it may face challenges from the external market forces. Combination materials and time-sensitive use of materials are expected to be crucial factors for choosing synthetic materials in future.

The use of regenerative medicine is highest in North America, particularly in the U.S., owing to increase in prevalence of chronic disorders, rise in demand for artificial organs due to organ failure, and presence of highly sophisticated healthcare infrastructure. Although the use of regenerative medicine in Asia-Pacific and LAMEA regions is low, the adoption rate is expected to increase due to the presence of high unmet medical needs and constant improvement in the healthcare infrastructure to treat chronic disorders. In addition, countries such as China, India, Australia, and Japan, contribute to the market growth owing to their large population and rise in demand for tissue-engineered and regenerative medicine products. These countries have varying demographics and cultural conditions, which highly influence their respective markets.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Regenerative Medicine Market- Global Opportunity Analysis and Industry Forecast, 2017-2023

  • Online Only
  • $3456
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8995
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo